MLS-2064

Overview

MLS-2064 is a 3'-substituted 7-haloindirubin with antitumor activity. MLS-2064 induces caspase-independent cell death. MLS-2064 induces dose-dependent cell death in various human cancer cell lines. MLS-2064 shows no significant inhibitory activity against CDK1 and CDK5 kinases, and only weak inhibitory activity against GSK-3 kinase ( IC 50 : 5 μM). MLS-2064 can be used in research related to colon cancer , breast cancer , lung cancer , prostate cancer , liver cancer , and neuroblastoma.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Signaling Pathways > GSK-3

Product Information

• Catalog No.: HY-111168
• CAS No.: 906660-74-0
• Molecular Formula: C22H24BrCl2N5O2
• Molecular Weight: 541.27
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source